AD/PD™ 2023: Striving for a better future for all those affected by neurodegenerative diseases
AD/PD™ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders
AD/PD™ focuses on basic science and translational and clinical research to bring you:
• New insights on disease mechanisms and etiologies.
• The latest findings from clinical trials.
• Innovative outlooks on therapy and prevention.
• Advances in diagnostic markers.
• Successful strategies to enhance collaboration between academia and industry.
• A great opportunity to interact with peers and experts in neurodegenerative disease.
The AD/PD™ Conference offers a high quality scientific program covering the most recent research, clinical trials, developments, and treatments in Alzheimer’s and Parkinson’s, with emphasis on overlaps and congruent results among AD. This provides participants with unparalleled and powerful insights into distinct neurodegenerative diseases in one setting to examine their similarities and differences.
Top Speakers in the Field
Science and education are the main forces behind AD/PD™ conferences and participants agree that the quality of the content and the educational value are what set it apart from other events in the field. In the CME Participant Evaluation Form 96% state that the event contributed to their professional development, while almost 97% agree that the quality of the speakers was excellent.
AD/PD™ in Numbers
A unique conference that provides a world class platform for clinical investigators and basic scientists to present, discuss and trade expertise on a broad range of themes and topics, AD/PD™ has gone from strength to strength attracting over 3,800 participants from 75 countries and over 2,200 abstracts in 2019.